Aytu BioPharma, Inc. (LON: 0A8M)

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $16.57M USD in the quarter ending September 30, 2024, a decrease of -6.98%. This brings the company's revenue in the last twelve months to $79.76M, down -18.25% year-over-year. In the fiscal year ending June 30, 2024, Aytu BioPharma had annual revenue of $81.00M, down -24.58%.

• Revenue (ttm): $79.76M
• Revenue Growth: -18.25%
• P/S Ratio: n/a
• Revenue / Employee: $781.95K
• Employees: 102
• Market Cap: 8.59M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	81.00M	-26.40M	-24.58%
Jun 30, 2023	107.40M	10.73M	11.10%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%
Jun 30, 2020	27.63M	20.31M	277.47%